Top-Rated StocksTop-RatedNASDAQ:ITCI Intra-Cellular Therapies (ITCI) Insider Trading & Ownership $61.32 +1.79 (+3.01%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$59.03▼$61.6650-Day Range$47.88▼$66.4452-Week Range$42.01▼$66.56Volume661,392 shsAverage Volume630,174 shsMarket Capitalization$5.88 billionP/E RatioN/ADividend YieldN/APrice Target$74.45 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$22.67 M ITCI Insider Buying and Selling by Quarter Get ITCI Insider Trade Alerts Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Intra-Cellular Therapies Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails4/17/2023Nostrand Robert L VanDirectorSell10,000$63.00$630,000.009,345 3/28/2023Mark NeumannEVPSell15,604$54.31$847,453.2445,339 3/13/2023Lawrence J. HinelineCFOSell5,582$44.93$250,799.26 3/13/2023Sharon MatesCEOSell20,565$44.99$925,219.351,130,309 3/13/2023Suresh K DurgamEVPSell7,344$45.04$330,773.7623,104 3/10/2023Lawrence J. HinelineCFOSell15,663$43.06$674,448.78 3/10/2023Mark NeumannEVPSell8,550$43.34$370,557.0057,357 3/10/2023Sharon MatesCEOSell41,770$43.15$1,802,375.501,130,309 3/1/2023Mark NeumannEVPSell7,241$50.01$362,122.4149,199 2/24/2023Lawrence J. HinelineCFOSell7,455$47.03$350,608.65 2/24/2023Mark NeumannEVPSell4,046$47.12$190,647.5256,440 2/24/2023Sharon MatesCEOSell22,590$47.03$1,062,407.701,100,309 2/24/2023Suresh K DurgamSVPSell7,906$47.14$372,688.8423,104 2/21/2023Lawrence J. HinelineCFOSell10,443$46.82$488,941.26 2/21/2023Mark NeumannEVPSell3,898$47.01$183,244.9852,580 2/21/2023Sharon MatesCEOSell27,848$46.83$1,304,121.841,100,309 2/21/2023Suresh K DurgamSVPSell8,354$46.84$391,301.3623,104 2/17/2023Lawrence J. HinelineCFOSell53,968$49.83$2,689,225.44 12/19/2022Joel S MarcusDirectorSell5,000$50.82$254,100.0029,233 12/13/2022Sharon MatesCEOSell33,083$55.00$1,819,565.001,100,309 12/1/2022Michael HalsteadEVPSell50,000$53.73$2,686,500.00 9/21/2022Lawrence J. HinelineCFOSell65,164$45.63$2,973,433.32 8/11/2022Nostrand Robert L VanDirectorSell30,000$57.13$1,713,900.009,043 (Data available from 1/1/2013 forward) ITCI Insider Trading Activity - Frequently Asked Questions Who is on Intra-Cellular Therapies's Insider Roster? The list of insiders at Intra-Cellular Therapies includes Christopher D Alafi, Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Nostrand Robert L Van, Rory B Riggs, Sharon Mates, and Suresh K Durgam. Learn more on insiders at ITCI. What percentage of Intra-Cellular Therapies stock is owned by insiders? 3.70% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings. Which Intra-Cellular Therapies insiders have been selling company stock? The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($1,849,776.03), Lawrence J Hineline ($10,094,662.22), Mark Neumann ($9,944,638.20), Michael Halstead ($11,098,104.28), Nostrand Robert L Van ($2,343,900.00), Rory B Riggs ($5,087,501.84), Sharon Mates ($13,282,189.82), and Suresh K Durgam ($2,531,081.26). How much insider selling is happening at Intra-Cellular Therapies? Insiders have sold a total of 1,279,991 Intra-Cellular Therapies shares in the last 24 months for a total of $63,659,310.36 sold. More Insider Trading Tools from MarketBeat Related Companies: Ionis Pharmaceuticals Insider Transactions Organon & Co. Insider Transactions IVERIC bio Insider Transactions Cerevel Therapeutics Insider Transactions Madrigal Pharmaceuticals Insider Transactions Catalent Insider Transactions Alkermes Insider Transactions Roivant Sciences Insider Transactions Perrigo Insider Transactions PTC Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 2 Cheap Stocks And 1 Cheap Sector The Insiders Are BuyingTyson Insiders Buy Shares At Multi-Year Low3 High-Yield Banks Insiders Are Buying Insiders Drive Volatility For Keurig Dr PepperInsiders Buy Wag! Group, Sell-Side Buys Too This page (NASDAQ:ITCI) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.